Stock A007630 POLUS BIOPHARM INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Polus BioPharm Inc.

Equities

A007630

KR7007630007

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Polus BioPharm Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Polus BioPharm Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
POLUS BioPharm Inc. cancelled the acquisition of GTS Korea Co., Ltd.
CI
Polus Holdings Co., Ltd acquired additional stake in POLUS BioPharm Inc. from Akaglobal Co. Ltd., G & D Solution Co., Ltd. and PNA Bio Co., Ltd.
CI
POLUS BioPharm Inc. agreed to acquire GTS Korea Co., Ltd. for KRW 3.6 billion.
CI
Two individuals acquired 0.01% stake in Amnis Co., Ltd. from GND Solution for KRW 10 million.
CI
I-Future Co., Ltd., i-KAIST Co., Ltd., I-Kaist Global Co., Ltd., and Akaglobal Co. Ltd. cancelled the acquisition to acquire 22.7% stake in Polus BioPharm Inc. from GS Teletech Co., Ltd.
CI
Akaglobal Co., Ltd. acquired 3.42% stake in GS Instruments Co. Ltd. from GS Teletech Co., Ltd. and 4 others for KRW 2 billion.
CI
KN Holdings acquired 0.86% stake in i-KAIST Lab Co., Ltd. from Akaglobal Co., Ltd. for approximately KRW 500 million.
CI
I-KAIST Co., Ltd. acquired 1.83% stake in GS Instruments Co. Ltd. from GS Teletech Co., Ltd. and 4 others for KRW 1.1 billion.
CI
Neptutors Co., Ltd. acquired approximately 6.83% stake in GS Instruments Co. Ltd. from GS Teletech Co., Ltd. and five others for approximately KRW 4 billion.
CI
Kanohi Co., Ltd. acquired 3.42% stake in GS Instruments Co. Ltd. from Youngsook Ko and others for KRW 1.9 billion.
CI
Neptutors Co., Ltd. and 23 others acquired 6% stake in GS Instruments Co. Ltd. from Unione Communications Co., Ltd. for KRW 1.9 billion.
CI
Neptutors Co., Ltd. and 24 others acquired 6.8% stake in GS Instruments Co. Ltd. from MAGNA Investment Co., Ltd. for KRW 2.2 billion.
CI
GS Instruments Co. Ltd. acquired GS Instech Co., Ltd. for KRW 1.4 billion.
CI
I-Future Co., Ltd., i-KAIST Co., Ltd., I-Kaist Global Co., Ltd., and Akaglobal Co. Ltd. signed a contract to acquire 22.7% stake in Polus BioPharm Inc. from GS Teletech Co., Ltd. for KRW 10 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A007630 Stock
  4. News Polus BioPharm Inc.
  5. Highlights